Is a complete STOK research report available?

No complete published report is available for Stoke Therapeutics, Inc. (STOK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · USD

$26.4

+0.29 (+1.1%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	27.6M
Net income (ttm)	-207.9M
EPS (ttm)	-$3.33
Shares out	64.5M
Volume	599,912
Beta	1.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 27.6M
Net income (ttm): -207.9M
EPS (ttm): -$3.33
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001623526
Company name	Stoke Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	86150R107
Earnings date	2026-10-29
Earnings time	amc
Employees	170
Employees change	42
Employees growth	32.81%
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-06-19
Is primary listing	Yes
Is SPAC	No
ISIN number	US86150R1077
Last 10-K release date	2026-03-16
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$26.42
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	STOK
U.S. state	Massachusetts
Website	https://www.stoketherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001623526

Company name

Stoke Therapeutics, Inc.

Country

United States

Country code

CUSIP number

86150R107

Earnings date

2026-10-29

Earnings time

amc

Employees

170

Employees change

Employees growth

32.81%

Enterprise value

$1.4B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2019-06-19

Is primary listing

Yes

Is SPAC

ISIN number

US86150R1077

Last 10-K release date

2026-03-16

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.7B

Market cap category

Small-Cap

Next earnings date

2026-10-29

Options

Yes

Price

$26.42

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

STOK

U.S. state

Massachusetts

Website

https://www.stoketherapeutics.com

Metric	Value
Earnings yield	-12.61%
EV/Sales	48.67x
FCF / EV yield	-13.46%
FCF yield	-10.66%
Forward EV/Sales	44.52x
Forward P/S	56.18x
P/B ratio	4.72x
P/S ratio	61.42x
Price / tangible book value	4.9x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-12.61%

EV/Sales

48.67x

FCF / EV yield

-13.46%

FCF yield

-10.66%

Forward EV/Sales

44.52x

Forward P/S

56.18x

P/B ratio

4.72x

P/S ratio

61.42x

Price / tangible book value

4.9x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	100%
Operating margin	-809.69%
Pretax margin	-758.23%
Profit per employee	$-1.2M
Revenue per employee	$162,282
ROA	-35.87%
ROA (5Y)	-21.02%
ROCE	-63.45%
ROE	-61.1%
ROE (5Y)	-38.65%
ROIC	-405.53%
SBC / revenue	135.72%
Tax / revenue	-4.63%

Metric

Value

Gross margin

100%

Operating margin

-809.69%

Pretax margin

-758.23%

Profit per employee

$-1.2M

Revenue per employee

$162,282

ROA

-35.87%

ROA (5Y)

-21.02%

ROCE

-63.45%

ROE

-61.1%

ROE (5Y)

-38.65%

ROIC

-405.53%

SBC / revenue

135.72%

Tax / revenue

-4.63%

Metric	Value
EPS growth years	3
Gross profit growth	-86.2%
Gross profit growth (Q)	-32.51%
Gross profit growth 3Y	46.11%
Net income growth years	2
Revenue growth	-86.2%
Revenue growth (Q)	-32.51%
Revenue growth (QoQ)	49.7%
Revenue growth 3Y	46.11%
Revenue growth years	2

Metric

Value

EPS growth years

Gross profit growth

-86.2%

Gross profit growth (Q)

-32.51%

Gross profit growth 3Y

46.11%

Net income growth years

Revenue growth

-86.2%

Revenue growth (Q)

-32.51%

Revenue growth (QoQ)

49.7%

Revenue growth 3Y

46.11%

Revenue growth years

Metric	Value
Capital expenditures	$-2.7M
Depreciation and amortization	$1.7M
EBIT	$-223.4M
EBITDA	$-221.6M
EPS	$-3.33
FCF per share	$-2.80
Financing cash flow	$181.7M
Free cash flow	$-180.7M
Free cash flow minus SBC	$-218.1M
Gross profit	$27.6M
Income taxes	$-1.3M
Investing cash flow	$7.7M
Net cash flow	$11.5M
Net income	$-207.9M
Operating cash flow minus SBC	$-215.4M
Operating income	$-223.4M
Revenue	$27.6M
Stock-based compensation	$37.4M

Metric

Value

Capital expenditures

$-2.7M

Depreciation and amortization

$1.7M

EBIT

$-223.4M

EBITDA

$-221.6M

EPS

$-3.33

FCF per share

$-2.80

Financing cash flow

$181.7M

Free cash flow

$-180.7M

Free cash flow minus SBC

$-218.1M

Gross profit

$27.6M

Income taxes

$-1.3M

Investing cash flow

$7.7M

Net cash flow

$11.5M

Net income

$-207.9M

Operating cash flow minus SBC

$-215.4M

Operating income

$-223.4M

Revenue

$27.6M

Stock-based compensation

$37.4M

Metric	Value
Altman Z-Score	16.92
Book value per share	$5.54
Debt / equity	0.01
Interest coverage	-4,752.7
Long-term assets	$71.4M
Long-term liabilities	$6.5M
Net cash (debt)	$351.6M
Net cash / market cap	20.75%
Net cash growth	0.06%
Net debt / equity	-1.02
Piotroski F-Score	2
Property, plant and equipment	$6.7M
Shareholders' equity	$345.5M
Tangible book value	$345.5M
Tangible book value per share	$5.54
Total assets	$394M
Total cash	$292.8M
Total debt	$2.7M
Total liabilities	$48.4M
WACC	11.18%

Metric

Value

Altman Z-Score

16.92

Book value per share

$5.54

Debt / equity

0.01

Interest coverage

-4,752.7

Long-term assets

$71.4M

Long-term liabilities

$6.5M

Net cash (debt)

$351.6M

Net cash / market cap

20.75%

Net cash growth

0.06%

Net debt / equity

-1.02

Piotroski F-Score

Property, plant and equipment

$6.7M

Shareholders' equity

$345.5M

Tangible book value

$345.5M

Tangible book value per share

$5.54

Total assets

$394M

Total cash

$292.8M

Total debt

$2.7M

Total liabilities

$48.4M

WACC

11.18%

Metric	Value
Asset turnover	0.07
Current assets	$322.5M
Current liabilities	$41.9M
Current ratio	7.69
Net working capital	$-10.4M
Quick ratio	7.19
Working capital	$280.6M
Working capital turnover	0.11

Metric

Value

Asset turnover

0.07

Current assets

$322.5M

Current liabilities

$41.9M

Current ratio

7.69

Net working capital

$-10.4M

Quick ratio

7.19

Working capital

$280.6M

Working capital turnover

0.11

Metric	Value
Buyback yield / dilution	-7.27%
Dividend yield	0%
Shareholder yield	-7.27%

Metric

Value

Buyback yield / dilution

-7.27%

Dividend yield

Shareholder yield

-7.27%

Metric	Value
150-day SMA	$30.35
1D price change	1.11%
1M price change	6.53%
1M total return	6.53%
1W price change	2.88%
1W total return	2.88%
1Y price change	-19.94%
1Y return CAGR	-19.95%
1Y total return	-19.94%
20-day SMA	$24.94
200-day SMA	$30.96
3M price change	-9.86%
3M total return	-9.86%
3Y price change	683.98%
3Y return CAGR	98.63%
3Y total return	683.98%
50-day SMA	$27.67
50-day SMA vs 200-day SMA	50under200
52-week high	$40.22
52-week high date	2026-03-10
52-week low	$20.32
52-week low date	2025-11-05
5Y price change	9.4%
5Y return CAGR	1.81%
5Y total return	9.4%
6M price change	-21.63%
6M total return	-21.63%
All-time high	$71.58
All-time high date	2021-01-20
All-time low	$3.35
All-time low date	2023-10-27
Average true range (ATR)	$1.26
Average volume	1.2M
Beta (1Y)	1.15
Beta (2Y)	1.74
Beta (5Y)	1.26
Change from 52-week high	-34.31%
Change from 52-week low	30.02%
Change from all-time high	-63.09%
Change from all-time low	688.66%
Change from open	1.46%
Day's gap	-0.34%
Dollar volume	$15.8M
High price	$26.45
Low price	$26.04
Monthly RSI	54.17
Open price	$26.04
Position in 52-week range	92.68%
Premarket change	0.08%
Premarket close	$26.13
Premarket price	$26.15
Premarket volume	133
Previous close	$26.13
Price vs 150-day SMA	-12.95%
Price vs 20-day SMA	5.92%
Price vs 200-day SMA	-14.67%
Price vs 50-day SMA	-4.5%
Relative volume	0.53
Return from IPO open	-3.49%
Return from IPO price	45.89%
RSI	53.11
Sharpe ratio	-0.18
Sharpe ratio (3Y)	1.15
Sharpe ratio (5Y)	0.38
Sortino ratio	-0.16
Sortino ratio (3Y)	2.19
Sortino ratio (5Y)	0.67
Volume	599.9K
Weekly RSI	43.69
YTD price change	-16.76%
YTD total return	-16.76%

Metric

Value

150-day SMA

$30.35

1D price change

1.11%

1M price change

6.53%

1M total return

6.53%

1W price change

2.88%

1W total return

2.88%

1Y price change

-19.94%

1Y return CAGR

-19.95%

1Y total return

-19.94%

20-day SMA

$24.94

200-day SMA

$30.96

3M price change

-9.86%

3M total return

-9.86%

3Y price change

683.98%

3Y return CAGR

98.63%

3Y total return

683.98%

50-day SMA

$27.67

50-day SMA vs 200-day SMA

50under200

52-week high

$40.22

52-week high date

2026-03-10

52-week low

$20.32

52-week low date

2025-11-05

5Y price change

9.4%

5Y return CAGR

1.81%

5Y total return

9.4%

6M price change

-21.63%

6M total return

-21.63%

All-time high

$71.58

All-time high date

2021-01-20

All-time low

$3.35

All-time low date

2023-10-27

Average true range (ATR)

$1.26

Average volume

1.2M

Beta (1Y)

1.15

Beta (2Y)

1.74

Beta (5Y)

1.26

Change from 52-week high

-34.31%

Change from 52-week low

30.02%

Change from all-time high

-63.09%

Change from all-time low

688.66%

Change from open

1.46%

Day's gap

-0.34%

Dollar volume

$15.8M

High price

$26.45

Low price

$26.04

Monthly RSI

54.17

Open price

$26.04

Position in 52-week range

92.68%

Premarket change

0.08%

Premarket close

$26.13

Premarket price

$26.15

Premarket volume

133

Previous close

$26.13

Price vs 150-day SMA

-12.95%

Price vs 20-day SMA

5.92%

Price vs 200-day SMA

-14.67%

Price vs 50-day SMA

-4.5%

Relative volume

0.53

Return from IPO open

-3.49%

Return from IPO price

45.89%

RSI

53.11

Sharpe ratio

-0.18

Sharpe ratio (3Y)

1.15

Sharpe ratio (5Y)

0.38

Sortino ratio

-0.16

Sortino ratio (3Y)

2.19

Sortino ratio (5Y)

0.67

Volume

599.9K

Weekly RSI

43.69

YTD price change

-16.76%

YTD total return

-16.76%

Metric	Value
Float	45.6M
Float percentage	70.69%
Shares change (QoQ)	4.68%
Shares change (YoY)	7.27%
Shares held by insiders	3.71%
Shares held by institutions	95.54%
Shares outstanding	64.5M
Short % of float	25.22%
Short % of shares	17.83%
Short ratio	12.5 days

Metric

Value

Float

45.6M

Float percentage

70.69%

Shares change (QoQ)

4.68%

Shares change (YoY)

7.27%

Shares held by insiders

3.71%

Shares held by institutions

95.54%

Shares outstanding

64.5M

Short % of float

25.22%

Short % of shares

17.83%

Short ratio

12.5 days

Stoke Therapeutics, Inc. (STOK)

Price

Financial snapshot

Fair-value bridge

Latest news · STOK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STOK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on STOK

Frequently asked questions